Articles of Interest

CEPI - the Coalition for Epidemic Preparedness Innovations

We want to stop future epidemics by developing new vaccines for a safer world.

Vaccines are one of the world’s most important health achievements. Yet their life-saving potential hasn’t yet been realised for many known and unknown epidemic threats, particularly in low-income countries, where the risks and needs are often greatest...


A Global Plan to Defend Against the Future's Deadliest Diseases

$460 million will go toward developing vaccines that prevent outbreaks like Ebola from taking the world by surprise.

The closing days of 2016 brought great news: The world now has an Ebola vaccine that’s 100 percent effective at preventing infections from the strain behind the recent west African outbreak...


U.S. Travelers Skip Measles Vaccines, Study Finds

More than half of U.S. adults who should get vaccinated against measles before traveling abroad don’t do it, a new study suggests. The U.S. Centers for Disease Control and Prevention recommends two doses of the measles, mumps and rubella (MMR) vaccine for adults traveling outside the U.S. who were born before 1957 and lack either a documented measles infection, records of adequate vaccination or a positive blood test for immunity to measles. ...



Six Things YOU Need to Know about Vaccines

1. We all need vaccines throughout our lives to help protect against serious diseases. Every year, tens of thousands of Americans get sick from diseases that could be prevented by vaccines - some people are hospitalized, some even die. Immunization is our best protection against these diseases. Vaccines are recommended for children, teens, and adults based on different factors like age, health conditions, lifestyle, jobs, and travel...


Vaccine Vision

A broad family of room temperature stable vaccines self administered via a painless patch...

read more
Featured Article
Featured Team Member

Dr. D. R. Henderson
Chief Executive Officer

Dan has experience and success in founding and building biopharmaceutical companies. He holds a Ph.D. in Medical Sciences from the University of New Mexico School of Medicine and was a postdoctoral scholar at Duke University Medical Center. He founded Microgenics Corporation. At Microgenics, Dan invented the CEDIA™ immunoassay system used in clinical laboratories throughout the world. CEDIA™ immunoassays now sell over $1B annually: please see www.usdiagnostics.roche.com and then search for CEDIA™ on their website; repeat at www.thermofisher.com. For this work, the American Association for Clinical Chemistry (AACC) awarded the 2015 biennial Ullman Prize for Technology Innovation to Dr. Henderson.

Dan also founded Calydon where he genetically engineered adenovirus targeting prostate cancer. For this work he was recognized as one of the two pioneers in the field of oncolytic virotherapy (Scientific American, “Tumor Busting Viruses”, October 2003). Calydon was sold to Cell Genesys. 2015 saw the first FDA approved oncolytic virus, a herpesvirus for melanoma.

Dr. Henderson also co-founded PaxVax, a manufacturer and developer of vaccines for travelers to countries without adequate water sanitation (Typhoid, Cholera and Hepatitis A) and the U.S. Military (Anthrax) (see www.paxvax.com). PaxVax was named Best Early-Stage Vaccine Biotech company at the 16th annual World Vaccine Congress in Washington, D.C., March, 2016 and received FDA approval for a Single Dose Oral Cholera vaccine in June. Dan holds 34 issued US Patents.

read more